Who are Ensysce Biosciences, Inc.'s major customers?

Ensysce Biosciences, Inc. (ENSC) key customers include: NIH-NIDA, LEISURE-ACQUISITION-CORP, Q-SMALLER-REPORTING-COMPANY. View the full customer network at chainsifter.com/chain/ENSC.

What sector is Ensysce Biosciences, Inc. in?

Ensysce Biosciences, Inc. (ENSC) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Ensysce Biosciences, Inc. (ENSC) Suppliers & Customers

0Suppliers

3Customers

3Debt Items

0Related Chains

Source-Backed Evidence Depth

Ensysce Biosciences, Inc. (ENSC) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

7Total relationships

1Distinct source URLs

5High confidence

0.823Average confidence

2026-07-01Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Ensysce Biosciences, Inc. Suppliers

No suppliers on recordEnsysce Biosciences, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

Ensysce Biosciences, Inc. Customers

Ticker	Name	Confidence	Evidence
NIH-NIDA	NIH-NIDA	92%	The Company recognizes revenue when costs related to the grants are incurred and assessed as reimbursable.
LEISURE-ACQUISITION-CORP	LEISURE-ACQUISITION-CORP	62%	osing of the Business Combination. Unless the context otherwise requires, references to “LACQ” refer to Leisure Acquisition Corp., a Delaware corporation, prior to the Closing. Overview Ensysce is a …
Q-SMALLER-REPORTING-COMPANY	Q-SMALLER-REPORTING-COMPANY	62%	months ended March 31, 2026 and $1.4 million the three months ended March 31, 2025, representing a decrease of $0.2 million. We expect future general and administrative expenses to approximate curren…

Ensysce Biosciences, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
ENSC-DEBT-9312	Warrants outstanding: 880000	90%	xbrl warrant detail from xbrl 2025-12-31.
ENSC-DEBT-9313	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2024-12-31.
ENSC-DEBT	Debt stack $245,849	90%	Market cache reports total debt of $245,849.

Ensysce Biosciences, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Ensysce Biosciences, Inc..

Ensysce Biosciences, Inc. Ownership

Holder	Name	Confidence	Evidence
ENSC-OWNER-PERCEPTIVE-ADVISORS-LLC	PERCEPTIVE ADVISORS LLC	90%	13F overlay lists PERCEPTIVE ADVISORS LLC as top holder; 15 tracked holders.

Ensysce Biosciences, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.

Ensysce Biosciences, Inc. Supply Chain